現在、Pub Med（米国国立医学図書館の生物医学文献データベース）に掲載されている156報中の150報は以下になります。
すべて原著論文で、学会発表は含めておりません。
1)Polymorphonuclear-rich and lymphocyte-rich tuberculous pleural effusion.
Okauchi S, Kagohashi K, Shiozawa T, Miyazaki K, Satoh H.
Ann Thorac Med. 2020 Jul-Sep;15(3):182.
2)Double gastric bubbles.
Okauchi S, Sasatani Y, Ohara G, Kagohashi K, Satoh H.
Tuberk Toraks. 2019 Jun;67(2):149-150.
3) Fatal contralateral pneumothorax in a patient with pneumonectomy.
Satoh H, Kagohashi K.
Tuberk Toraks. 2020 Dec;68(4):461-462.
4)Early pleural effusion control in patients with lung cancer.
Okauchi S, Kagohashi K, Shiozawa T, Miyazaki K, Satoh H.
Respirology. 2020 Nov;25(11):1207.
5)Emphysema affects the number and characteristics of solitary pulmonary nodules.
Kagohashi K, Miyazaki K, Shiozawa T, Satoh H.
Pol Arch Intern Med. 2020 Mar 27;130(3):261.
6)Pleural fluid due to papillary thyroid cancer.
Tamura T, Shiozawa T, Satoh H, Kurishima K, Kagohashi K, Takayashiki N, Hizawa N.
Oncol Lett. 2019 Jul;18(1):962-966.
7)Terminological Usage Related to Dyspnea by Nursing Staff: A Cross-Sectional Questionnaire Survey.
Nemoto Y, Suzuki S, Okauchi S, Kagohashi K, Satoh H.
Asian Pac Isl Nurs J. 2020;4(4):144-150.
8)Immuno-checkpoint inhibitor-associated hyper-eosinophilia and tumor shrinkage.
Osawa H, Okauchi S, Taguchi S, Kagohashi K, Satoh H.
Tuberk Toraks. 2018 Mar;66(1):80-83.
9)Prevalence of COPD.
Kagohashi K, Satoh H, Kurishima K.
Respirology. 2014 May;19(4):616.
10)Combined Atezolizumab and Chemotherapy for a Patient With Double Primary Cancers.
Okauchi S, Sasatani Y, Ohara G, Kagohashi K, Satoh H.
In Vivo. 2020 Jan-Feb;34(1):389-392.
11)Change in Body Weight and Serum Albumin Levels in Febrile Neutropenic Lung Cancer Patients.
Kayauchi N, Nakagawa Y, Oteki T, Kagohashi K, Satoh H.
Asian Pac Isl Nurs J. 2020;5(3):120-127.
12)Oligo-recurrence from anaplastic lymphoma kinase-rearranged lung adenocarcinoma.
Sasatani Y, Okauchi S, Ohara G, Kagohashi K, Iguchi K, Kawai K, Satoh H.
Adv Respir Med. 2019;87(5):301-304.
13)Duodenal and pancreas metastasis from lung cancer.
Tamura T, Ohara G, Kagohashi K, Takayashiki N, Satoh H.
Tuberk Toraks. 2017 Jun;65(2):165-168.
14)EGFR Mutation in Patients with Lung Adenosquamous Cell Carcinoma.
Tamura T, Kagohashi K, Satoh H.
Ann Surg Oncol. 2017 Dec;24(Suppl 3):675.
15)Prolonged response after the discontinuation of nivolumab after resistance to gefitinib.
Sasatani Y, Okauchi S, Ohara G, Kagohashi K, Satoh H.
Clin Respir J. 2019 Oct;13(10):657-658.
16)Chronic expanding hematoma in the chest: A case report.
Sakuma T, Takayashiki N, Iguchi K, Kagohashi K, Satoh H, Nakazawa K, Hizawa N.
Exp Ther Med. 2018 Jun;15(6):5457-5460.
17)Positive FDG PET/CT findings in a patient with pneumoconiosis.
Tamura T, Ohara G, Kagohashi K, Satoh H.
Tuberk Toraks. 2016 Dec;64(4):319-320.
18)Successfully managed combined pulmonary fibrosis and emphysema in a lung large cell neuroendocrine carcinoma patient treated with pembrolizumab.
Kagohashi K, Satoh H.
Clin Respir J. 2021 May;15(5):574-575.
19)Hematogenous muscular metastasis of NSCLC in FDG-PET/CT.
Satoh H, Tamura T, Kagohashi K.
Contemp Oncol (Pozn). 2015;19(5):422.
20)Imaging characteristics of nontuberculous mycobacterial pulmonary nodules.
Nishino K, Iguchi K, Ishibashi O, Sasatani Y, Ohara G, Kagohashi K, Satoh H.
Rom J Intern Med. 2021 Nov 20;59(4):369-374.
21)Lung cancer in patients with combined pulmonary fibrosis and emphysema.
Tamura T, Kagohashi K, Satoh H.
Clin Respir J. 2018 Mar;12(3):1304.
22)Adverse effect of muscle damage due to osimertinib.
Satoh H, Miyazaki K, Kagohashi K.
Cancer Treat Res Commun. 2021 May 8;28:100389. doi: 10.1016/j.ctarc.2021.100389. Online ahead of print.
23)Bochdalek hernia in a middle-aged man.
Watanabe H, Tamura T, Iguchi K, Kagohashi K, Satoh H.
Tuberk Toraks. 2015;63(1):65-6..
24)Clinical improvement by tiotropium plus olodaterol.
Tamura T, Kagohashi K, Satoh H.
Respir Med. 2017 Apr;125:104.
25)Tuberculous peritonitis in a patient with rheumatoid arthritis.
Kagohashi K, Ohara G, Kurishima K, Satoh H.
J Clin Rheumatol. 2014 Jan;20(1):57-8.
26)Long-term maintenance of nutritional status with ninjinyoueito in terminal patients with chronic respiratory disease: Two case reports.
Sasatani Y, Okauchi S, Ohara G, Kagohashi K, Satoh H.
Biomed Rep. 2020 Mar;12(3):121-124. doi: 10.3892/br.2019.1267.
27)Lung adenocarcinoma with endobronchial growth.
Kagohashi K, Kurishima K, Ishikawa H, Satoh H.
Tuberk Toraks. 2011;59(4):392-5.
28)Pioglitazone-induced Pulmonary Injury in a Very Elderly Patient.
Katayama K, Kumagai R, Isono M, Fujihara K, Yagyu H, Ohara G, Kagohashi K, Satoh H.
Intern Med. 2016;55(13):1779-82.
29)Pemetrexed and bevacizumab-containing chemotherapy for pleomorphic carcinoma of the lung.
Tamura T, Ohara G, Kagohashi K, Kawaguchi M, Kurishima K, Satoh H.
Mol Clin Oncol. 2016 Apr;4(4):616-618.
30)Hoarseness due to subcutaneous emphysema and pneumomediastinum.
Ohara G, Kagohashi K, Aoyagi Y, Nakazawa K, Kurishima K, Satoh H.
J Emerg Med. 2012 Dec;43(6):e491.
31)Pneumothorax with postoperative complicated pleural adhesion.
Satoh H, Kurishima K, Kagohashi K.
Tuberk Toraks. 2013;61(4):357-9.
32)Cavitary pulmonary metastases of pancreas cancer.
Tamura T, Nakazawa K, Kagohashi K, Kurishima K, Satoh H.
J Gastrointest Cancer. 2013 Jun;44(2):222-4.
33)Superficial-type endobronchial metastases from colon cancer: A case report.
Kurishima K, Satoh H, Kagohashi K, Miyazaki K, Tamura T, Shiozawa T, Ohara G, Kawaguchi M, Takayashiki N, Hizawa N.
Oncol Lett. 2014 Nov;8(5):2310-2312.
34)Outcome of SARS-CoV-2 infection in patients with severe asthma on biologics.
Kagohashi K, Miyazaki K, Satoh H.
Respir Med. 2021 Mar 6:106358..
35)Empyema in a rheumatoid patient.
Kagohashi K, Satoh H, Nishimagi H.
South Med J. 2009 Jun;102(6):668-9.
36) Bronchial damage and diffuse alveolar hemorrhage following chlorine gas inhalation: A case report.
Uemura K, Isono M, Kagohashi K, Hasegawa R, Satoh H.
Exp Ther Med. 2017 Nov;14(5):5126-5128.
37)Effect of Shakuyakukanzoto on Chemotherapy-Induced Hiccups in Patients with Lung Cancer.
Kamoshida S, Okauchi S, Osawa H, Ohara G, Kagohashi K, Satoh H.
Eurasian J Med. 2021 Feb;53(1):2-4.
38)Successful dacomitinib treatment after osimertinib resistance in a patient with lung adenocarcinoma.
Kagohashi K, Shiozawa T, Miyazaki K, Satoh H.
Clin Respir J. 2021 Jul;15(7):851-852.
39)Pseudoprogression during successful rechallenge of immune checkpoint inhibitor in a NSCLC patient.
Kagohashi K, Miyazaki K, Shiozawa T, Satoh H.
Adv Respir Med. 2021;89(3):316-319.
40) Long-term control in a patient with metastatic lung adenocarcinoma after discontinuation of nivolumab.
Satoh H, Miyazaki K, Shiozawa T, Kagohashi K.
J Oncol Pharm Pract. 2021 Jun;27(4):1052-1053.
41)Small cell lung cancer with endobronchial growth: A case report.
Kurishima K, Kagohashi K, Miyazaki K, Tamura T, Ohara G, Kawaguchi M, Satoh H.
Oncol Lett. 2013 Aug;6(2):553-555.
42)Isolated spleen recurrence in a patient with lung adenocarcinoma: A case report.
Iguchi K, Ishibashi O, Kondo T, Kagohashi K, Takayashiki N, Satoh H.
Exp Ther Med. 2015 Aug;10(2):733-736.
43)Fluoro-deoxyglucose-positron emission tomography/CT scan in superior vena cava syndrome due to radiation-induced fibrosis.
Kagohashi K, Satoh H.
Rep Pract Oncol Radiother. 2021 Jun 9;26(3):451-453.
44)Incidental esophageal submucosal tumor detection by chest radiography: A case report.
Tadano S, Kondo T, Watanabe M, Takayashiki N, Shiozawa T, Ohara G, Kagohashi K, Kurishima K, Satoh H.
Exp Ther Med. 2014 Dec;8(6):1831-1834.
45)Endostatin levels in exudative pleural effusions.
Sumi M, Kagohashi K, Satoh H, Ishikawa H, Funayama Y, Sekizawa K.
Lung. 2003 Nov-Dec;181(6):329-34.
46) Pleural dissemination disclosed by 18F-FDG-PET/CT.
Ohara G, Kagohashi K, Kurishima K, Satoh H.
Intern Med. 2011;50(16):1783.
47)Measuring the success of transbronchial needle aspiration.
Satoh H, Kagohashi K, Ohtsuka M.
Respir Med. 2007 May;101(5):1044.
48)Nodular metastatic lung tumor from thyroid carcinoma.
Kurishima K, Kagohashi K, Ishibashi A, Takayashiki N, Satoh H.
Ann Thorac Cardiovasc Surg. 2014;20 Suppl:449-52.
49)Skin metastasis from small cell lung cancer.
Kurishima K, Kagohashi K, Ohara G, Miyazaki K, Kawaguchi M, Takayashiki N, Satoh H.
Tuberk Toraks. 2014;62(2):147-50.
50)Lung cancer with spontaneous regression of primary and metastatic sites: A case report.
Ogawa R, Watanabe H, Yazaki K, Fujita K, Tsunoda Y, Nakazawa K, Homma S, Kagohashi K, Satoh H, Hizawa N.
Oncol Lett. 2015 Jul;10(1):550-552.
51)Treatment of choroid metastasis from lung adenocarcinoma with bevacizumab-containing chemotherapy: A case report.
Makabe K, Kurishima K, Shiozawa T, Miyazaki K, Ohara G, Kagohashi K, Satoh H, Hizawa N.
Exp Ther Med. 2016 Jan;11(1):239-242.
52)Tibia metastasis from small cell lung cancer.
Kurishima K, Kagohashi K, Mammoto T, Satoh H.
Tuberk Toraks. 2014;62(1):89-90.
53)Specific organ metastases and survival in metastatic non-small-cell lung cancer.
Tamura T, Kurishima K, Nakazawa K, Kagohashi K, Ishikawa H, Satoh H, Hizawa N.
Mol Clin Oncol. 2015 Jan;3(1):217-221.
54)Upper airway mass mimicking near-fatal asthma.
Ohara G, Satoh H, Kagohashi K, Ohtsuka M, Sekizawa K.
J Emerg Med. 2005 Jul;29(1):104-5.
55)Specific organ metastases and survival in small cell lung cancer.
Nakazawa K, Kurishima K, Tamura T, Kagohashi K, Ishikawa H, Satoh H, Hizawa N.
Oncol Lett. 2012 Oct;4(4):617-620.
56)Pneumomediastinum in a patient with pneumocystis jirovecii pneumonia.
Kaji Y, Ohara G, Kagohashi K, Satoh H.
Intern Med. 2012;51(16):2251.
57)Recurrent pulmonary synovial sarcoma effectively treated with amrubicin: A case report.
Satoh H, Takayashiki N, Shiozawa T, Miyazaki K, Ohara G, Kagohashi K, Kurishima K, Sugita S, Aoyama T, Hasegawa T, Hizawa N.
Exp Ther Med. 2015 May;9(5):1947-1949.
58)[Thromboembolism in lung cancer patients].
Kanemoto K, Matsuno Y, Kagohashi K, Satoh H, Ohtsuka M, Sekizawa K.
Nihon Kokyuki Gakkai Zasshi. 2002 Nov;40(11):863-8.
59)A tracheobronchial adenoid cystic carcinoma incidentally detected by chest radiography and pulmonary function test.
Ono S, Namikawa H, Nakajima H, Kagohashi K, Satoh H, Furukawa K.
Adv Respir Med. 2021;89(3):320-323.
60)Isolated solitary brain metastasis as a relapse of small cell lung cancer.
Sakurai H, Kurishima K, Homma S, Kagohashi K, Miyazaki K, Kawaguchi M, Satoh H, Hizawa N.
Oncol Lett. 2013 Oct;6(4):1108-1110.
61)Chronic eosinophilic pneumonia with subpleural curvilinear shadow.
Kagohashi K, Ohara G, Kurishima K, Kawaguchi M, Nakayama H, Ishikawa H, Satoh H.
Acta Medica (Hradec Kralove). 2011;54(1):45-8.
62)Blood-patch pleurodesis for pneumothorax in lung fibrosis due to progressive systemic sclerosis: A case report.
Kagohashi K, Ohara G, Shiozawa T, Tamura T, Miyazaki K, Kurishima K, Satoh H, Hizawa N.
Exp Ther Med. 2014 Dec;8(6):1919-1921.
63)Peritoneal and meningeal relapse from lung adenocarcinoma after a response to gefitinib: A case report.
Kurishima K, Miyazaki K, Tamura T, Ohara G, Kagohashi K, Kawaguchi M, Satoh H.
Mol Clin Oncol. 2013 Jul;1(4):785-787.
64)FDG-PET/CT scan in a skin metastasis from lung cancer.
Kurishima K, Kagohashi K, Taguchi S, Satoh H.
Tuberk Toraks. 2014;62(2):170-1.
65)Axillary lymph node metastasis in lung cancer.
Satoh H, Ishikawa H, Kagohashi K, Kurishima K, Sekizawa K.
Med Oncol. 2009;26(2):147-50.
66)Long-term safety of budesonide/formoterol for the treatment of elderly patients with bronchial asthma.
Kagohashi K, Satoh H, Ohara G, Miyazaki K, Kawaguchi M, Kurishima K, Hizawa N.
Exp Ther Med. 2014 Apr;7(4):1005-1009.
67)Age-dependent decline in renal function in patients with lung cancer.
Ohara G, Kurishima K, Nakazawa K, Kawaguchi M, Kagohashi K, Ishikawa H, Hizawa N, Satoh H.
Oncol Lett. 2012 Jul;4(1):38-42.
68)Letter to the Editor Regarding “Cutaneous Toxicities in Lung Cancer Patients on Immune Checkpoint Inhibitor Therapy”.
Satoh H, Miyazaki K, Kagohashi K.
Clin Lung Cancer. 2021 Feb 27:S1525-7304(21)00051-6.
69)Recovery from carcinomatous meningitis by erlotinib.
Ohara G, Kagohashi K, Kurishima K, Kawaguchi M, Nakayama H, Satoh H.
Onkologie. 2011;34(7):394-5.
70)Retroperitoneal abscess shortly after chemotherapy for lung cancer: A case report.
Ohara G, Kondo T, Kagohashi K, Watanabe H, Kawaguchi M, Kurishima K, Satoh H, Hizawa N.
Mol Clin Oncol. 2014 Mar;2(2):302-304.
71)Brain metastasis as an isolated late recurrence in small-cell lung cancer.
Kurishima K, Homma S, Kagohashi K, Miyazaki K, Kawaguchi M, Satoh H, Hizawa N.
Mol Clin Oncol. 2014 Mar;2(2):305-307.
72)Severe airflow obstruction in a patient with ulcerative colitis and toxic epidermal necrolysis: A case report.
Taguchi S, Furuta J, Ohara G, Kagohashi K, Satoh H.
Exp Ther Med. 2015 May;9(5):1944-1946.
73)Serum levels of cystatin C in elderly lung cancer patients.
Ohara G, Miyazaki K, Kurishima K, Kagohashi K, Ishikawa H, Satoh H, Hizawa N.
Oncol Lett. 2012 Feb;3(2):303-306.
74)Elevated serum levels of two anti-neutrophil cytoplasmic antibodies in a lung cancer patient: A case report.
Okauchi S, Tamura T, Kagohashi K, Kawaguchi M, Satoh H.
Biomed Rep. 2016 Oct;5(4):511-513.
75)Chemotherapy-induced complications in patients with lung cancer: An evaluation by pharmacists.
Ishikawa A, Ohara G, Nakazawa K, Tamura T, Sato S, Kagohashi K, Kurishima K, Ito Y, Satoh H.
Mol Clin Oncol. 2013 Jan;1(1):65-68.
76) Changes in Body Weight and Serum Albumin Levels in Patients Requiring Home Long-term Oxygen Therapy.
Kayauchi N, Ojima E, Kagohashi K, Satoh H.
Asian Pac Isl Nurs J. 2021;5(4):199-206.
77)Pneumonitis due to an herbal medicine, Otsu-ji-to.
Hiraya D, Kagohashi K, Satoh H.
Eur J Intern Med. 2010 Jun;21(3):244.
78)Interstitial lung disease in patients with small cell lung cancer.
Miyazaki K, Satoh H, Kurishima K, Nakamura R, Ishikawa H, Kagohashi K, Hizawa N.
Med Oncol. 2010 Sep;27(3):763-7.
79)Adenosquamous cell lung cancer successfully treated with gefitinib: A case report.
Kurishima K, Ohara G, Kagohashi K, Watanabe H, Takayashiki N, Ishibashi A, Satoh H.
Mol Clin Oncol. 2014 Mar;2(2):282-284.
80)Successful treatment of EGFR-mutated non-small cell lung cancer with reduced-dose gefitinib: A case report.
Watanabe H, Tamura T, Kagohashi K, Takayashiki N, Kurishima K, Satoh H, Hizawa N.
Exp Ther Med. 2015 Jul;10(1):386-388.
81)Psychotropic drugs for terminally ill patients with respiratory disease.
Kanemoto K, Satoh H, Kagohashi K, Kurishima K, Ishikawa H, Ohtsuka M.
Tuberk Toraks. 2007;55(1):5-10.
82)Eosinophlic pneumonia in a patient with anticentromere antibody.
Satoh H, Kagohashi K, Ohara G, Miyazaki K, Kurishima K.
Reumatol Clin. 2014 May-Jun;10(3):198.
83) Production of CA125 by human lung cancer cell lines.
Homma S, Satoh H, Kagohashi K, Fujiwara M, Kamma H, Sekizawa K.
Clin Exp Med. 2004 Dec;4(3):139-41.
84)Use of tiotropium in patients with COPD aged 80 years and older.
Satoh H, Kagohashi K, Ohara G, Sato S, Miyazaki K, Nakazawa K, Tamura T, Kurishima K, Kawaguchi M, Hizawa N.
Exp Ther Med. 2013 Apr;5(4):997-1000.
85)Acute-onset type 1 diabetes mellitus caused by nivolumab in a patient with advanced pulmonary adenocarcinoma.
Kumagai R, Muramatsu A, Nakajima R, Fujii M, Kaino K, Katakura Y, Okumura N, Ohara G, Kagohashi K, Satoh H, Yagyu H.
J Diabetes Investig. 2017 Nov;8(6):798-799.
86)Successfully chest irradiation for an advanced squamous cell lung cancer patient with predialysis renal insufficiency.
Tamura T, Ohara G, Kagohashi K, Satoh H.
Tuberk Toraks. 2017 Sep;65(3):255-257.
87)Safety creatinine clearance level for platinum chemotherapy in lung cancer patients.
Ohara G, Miyazaki K, Kurishima K, Kagohashi K, Ishikawa H, Satoh H, Hizawa N.
Oncol Lett. 2012 Feb;3(2):311-314.
88)Lung cancer patients with previous or simultaneous urologic cancers.
Miyazaki K, Satoh H, Kagohashi K, Kurishima K, Ishikawa H, Ohtsuka M, Sekizawa K.
Med Oncol. 2008;25(4):443-6.
89)Brain metastasis as the first manifestation of lung cancer.
Kagohashi K, Satoh H, Yamashita YT, Sekizawa K.
Am J Med. 2003 Apr 1;114(5):420.
90)A Long-Term Control of Intramedullary Thoracic Spinal Cord Metastasis from Small Cell Lung Cancer.
Osawa H, Okauchi S, Ohara G, Kagohashi K, Satoh H.
Acta Medica (Hradec Kralove). 2018;61(2):57-59.
91) Lung cancer in patients aged 80 years and over.
Satoh H, Kurishima K, Nakamura R, Ishikawa H, Kagohashi K, Ohara G, Ishikawa S, Ohtsuka M, Sekizawa K, Hizawa N.
Lung Cancer. 2009 Jul;65(1):112-8.
92)Time-to-treatment failure and peripheral eosinophils in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
Osawa H, Shiozawa T, Okauchi S, Miyazaki K, Kodama T, Kagohashi K, Nakamura R, Satoh H, Hizawa N.
Pol Arch Intern Med. 2021 Jun 28.
93)Application of conditional probability analysis to distant metastases from lung cancer.
Oikawa A, Takahashi H, Ishikawa H, Kurishima K, Kagohashi K, Satoh H.
Oncol Lett. 2012 Mar;3(3):629-634.
94)Effect of rikkunshi-to treatment on chemotherapy-induced appetite loss in patients with lung cancer: A prospective study.
Oteki T, Ishikawa A, Sasaki Y, Ohara G, Kagohashi K, Kurishima K, Satoh H.
Exp Ther Med. 2016 Jan;11(1):243-246.
95)Lung cancer patients with previous or simultaneous the upper aerodigestive cancers.
Kagohashi K, Satoh H, Kurishima K, Ishikawa H, Ohtsuka M, Sekizawa K.
Tuberk Toraks. 2009;57(2):192-7.
96)A population-based study of gefitinib in patients with non-small cell lung cancer.
Hayashibara K, Satoh H, Shinohara Y, Inagaki M, Kaburagi T, Hashimoto T, Kurishima K, Ishikawa H, Ichimura H, Nawa T, Funayama Y, Matsumura T, Kagohashi K, Endo T, Furukawa K, Kishi K, Sumi M, Kamiyama K, Ishikawa S.
Med Oncol. 2009;26(2):222-7.
97)Ossification and increased bone mineral density with zoledronic acid in a patient with lung adenocarcinoma: A case report.
Kurishima K, Ohara G, Kagohashi K, Takayashiki N, Tamura T, Shiozawa T, Miyazaki K, Kawaguchi M, Satoh H, Hizawa N.
Exp Ther Med. 2014 Oct;8(4):1267-1270.
98)Successful pemetrexed-containing chemotherapy for epidermal growth factor receptor mutation-positive adenosquamous cell carcinoma of the lung: A case report.
Watanabe H, Tamura T, Kagohashi K, Kawaguchi M, Kurishima K, Satoh H.
Mol Clin Oncol. 2016 Apr;4(4):628-630.
99)Patients with lung cancer with metachronous or synchronous gastric cancer.
Kurishima K, Satoh H, Kagohashi K, Homma S, Nakayama H, Ohara G, Ishikawa H, Hizawa N.
Clin Lung Cancer. 2009 Nov;10(6):422-5.
100)Association between peripheral eosinophils and clinical outcomes in patients with non-small cell lung cancer treated with immune checkpoint inhibitors.
Okauchi S, Shiozawa T, Miyazaki K, Nishino K, Sasatani Y, Ohara G, Kagohashi K, Sato S, Kodama T, Satoh H, Hizawa N.
Pol Arch Intern Med. 2021 Feb 26;131(2):152-160.
101)Effect of a traditional herbal medicine, hangekobokuto, on the sensation of a lump in the throat in patients with respiratory diseases.
Kagohashi K, Tamura T, Ohara G, Satoh H.
Biomed Rep. 2016 Mar;4(3):384-386.
102)Serum KL-6 levels in lung cancer patients with or without interstitial lung disease.
Miyazaki K, Kurishima K, Kagohashi K, Kawaguchi M, Ishikawa H, Satoh H, Hizawa N.
J Clin Lab Anal. 2010;24(5):295-9.
103) Lung cancer superimposed opacity of aortic arch.
Kurishima K, Kagohashi K, Satoh H.
Tuberk Toraks. 2014;62(2):172-3.
104)Non-interventional management of small pneumothorax in the very elderly.
Kagohashi K, Ohara G, Kurishima K, Satoh H.
Tuberk Toraks. 2013;61(4):342-5.
105)Observational study on the efficacy and safety of erlotinib in patients with non-small cell lung cancer.
Kaburagi T, Satoh H, Hayashihara K, Endo T, Hizawa N, Kurishima K, Nishimura Y, Hashimoto T, Nakamura H, Kishi K, Inagaki M, Nawa T, Ichimura H, Ishikawa H, Kagohashi K, Fukuoka T, Shinohara Y, Kamiyama K, Sato Y, Sakai M, Matsumura T, Uchiumi K, Furukawa K.
Oncol Lett. 2013 Feb;5(2):435-439.
106)Pleural mass originating from a gonadal teratoma.
Kurishima K, Kagohashi K, Ando S, Satoh H.
Intern Med. 2014;53(8):919.
107)Response to alectinib after one year of discontinuation of crizotinib in anaplastic lymphoma kinase-positive non-small-cell lung cancer: A case report.
Watanabe H, Tamura T, Shiozawa T, Ohara G, Kagohashi K, Kawaguchi M, Kurishima K, Satoh H, Hizawa N.
Mol Clin Oncol. 2015 Jul;3(4):889-891.
108)Pulmonary arteriovenous communications in an elderly patient.
Kurishima K, Kagohashi K, Ohra G, Satoh H.
Intern Med. 2012;51(2):225-6.
109)Expression of hnRNP A2/B1 proteins in small airway epithelial cells.
Satoh H, Ishikawa H, Kamma H, Fujiwara M, Homma S, Kagohashi K, Ohtsuka M, Sekizawa K.
Int J Mol Med. 2004 Oct;14(4):605-8.
110)Squamous cell carcinoma antigen in lung cancer and nonmalignant respiratory diseases.
Kagohashi K, Satoh H, Kurishima K, Kadono K, Ishikawa H, Ohtsuka M, Sekizawa K.
Lung. 2008 Sep-Oct;186(5):323-6.
111) Optimal cutoff points of CYFRA21-1 for survival prediction in non-small cell lung cancer patients based on running statistical analysis.
Takahashi H, Kurishima K, Ishikawa H, Kagohashi K, Kawaguchi M, Satoh H.
Anticancer Res. 2010 Sep;30(9):3833-7.
112)Impact of interstitial lung disease on survival for patients with non-small cell lung cancer.
Miyazaki K, Satoh H, Kurishima K, Nakamura R, Ishikawa H, Kagohashi K, Ohara G, Hizawa N.
Anticancer Res. 2009 Jul;29(7):2671-4.
113)Comparison between FDG-PET/CT and bone scan in bone metastasis from NSCLC.
Tamura T, Kagohashi K, Kurishima K, Satoh H.
Contemp Oncol (Pozn). 2014;18(6):452.
114)Prognostic value of tumor disappearance rate on computed tomography in advanced-stage lung adenocarcinoma.
Haraguchi N, Satoh H, Kikuchi N, Kagohashi K, Ishikawa H, Ohtsuka M.
Clin Lung Cancer. 2007 Mar;8(5):327-30.
115)Increased serum levels of endostatin in patients with idiopathic pulmonary fibrosis.
Sumi M, Satoh H, Kagohashi K, Ishikawa H, Sekizawa K.
J Clin Lab Anal. 2005;19(4):146-9.
116)Fatal hepatic failure due to gemcitabine and vinorelbine.
Kagohashi K, Funayama Y, Satoh H, Sekizawa K.
Ann Oncol. 2003 Jun;14(6):960.
117)Portal vein tumor thrombus of liver metastasis from lung cancer.
Ogawa R, Kodama T, Kurishima K, Kagohashi K, Satoh H.
Acta Medica (Hradec Kralove). 2009;52(4):163-6.
118)Effect of acid suppressants on the efficacy of tyrosine kinase inhibitors in patients with epidermal growth factor receptor-mutated non-small-cell lung cancer.
Miyazaki K, Sato S, Kodama T, Tamura T, Kagohashi K, Satoh H, Hizawa N.
Mol Clin Oncol. 2016 May;4(5):873-877.
119)Recovery from paraplegia with administration of erlotinib in a patient with lung adenocarcinoma.
Kurishima K, Kagohashi K, Mammoto T, Satoh H.
Contemp Oncol (Pozn). 2014;18(2):140-2.
120)Comparison of neurone-specific enolase and pro-gastrin releasing peptide in the prognostic evaluation of small cell lung cancer patients.
Satoh H, Kagohashi K, Kurishima K, Ishikawa H, Ohtsuka M.
Clin Oncol (R Coll Radiol). 2006 Nov;18(9):720.
121)Successful Afatinib Therapy after Resistance to EGFR-TKI in a Patient with Advanced Adenosquamous Cell Lung Cancer.
Tamura T, Kagohashi K, Satoh H.
Oncol Res Treat. 2015;38(6):316-7.
122)Idiopathic interstitial pneumonias associated with lung cancer.
Kagohashi K, Miyazaki K, Satoh H.
Intern Med. 2009;48(18):1721; author reply 1723.
123)Volume doubling time of lung cancers detected in a chest radiograph mass screening program: Comparison with CT screening.
Kanashiki M, Tomizawa T, Yamaguchi I, Kurishima K, Hizawa N, Ishikawa H, Kagohashi K, Satoh H.
Oncol Lett. 2012 Sep;4(3):513-516.
124)A re-evaluation of squamous cell carcinoma antigen (SCC) as a serum marker for non-small cell lung cancer.
Kagohashi K, Satoh H, Ishikawa H, Ohtsuka M, Sekizawa K.
Med Oncol. 2008;25(2):187-9.
125)Liver metastasis at the time of initial diagnosis of lung cancer.
Kagohashi K, Satoh H, Ishikawa H, Ohtsuka M, Sekizawa K.
Med Oncol. 2003;20(1):25-8.
126) Cerebral hemorrhage in the course of stereotactic radiosurgery.
Kagohashi K, Satoh H, Homma T, Ohtsuka M, Sekizawa K.
Clin Oncol (R Coll Radiol). 2002 Jun;14(3):260-1.
127)Efficacy of tyrosine kinase inhibitors in non-small-cell lung cancer patients undergoing dose reduction and those with a low body surface area.
Sato S, Kurishima K, Miyazaki K, Kodama T, Ishikawa H, Kagohashi K, Tamura T, Homma S, Satoh H, Hizawa N.
Mol Clin Oncol. 2014 Jul;2(4):604-608.
128)Successfully treated acute exacerbation of idiopathic interstitial pneumonia in an octogenarian.
Kobayashi K, Kinoshita K, Kagohashi K, Takeda Y, Satoh H.
Australas J Ageing. 2009 Dec;28(4):219.
129)Erlotinib for elderly patients with non-small-cell lung cancer: Subset analysis from a population-based observational study by the Ibaraki Thoracic Integrative (POSITIVE) Research Group.
Kurishima K, Satoh H, Kaburagi T, Nishimura Y, Shinohara Y, Inagaki M, Endo T, Saito T, Hayashihara K, Hizawa N, Nakamura H, Nawa T, Kagohashi K, Kishi K, Ishikawa H, Ichimura H, Hashimoto T, Sato Y, Sakai M, Kamiyama K, Matsumura T, Unoura K, Fukuoka T, Uchiumi K, Nomura A, Furukawa K.
Mol Clin Oncol. 2013 Sep;1(5):828-832.
130)Bilateral axillary node metastases from anaplastic lymphoma kinase positive non-small cell lung cancer.
Kurishima K, Kagohashi K, Satoh H.
J Cancer Res Ther. 2015 Oct-Dec;11(4):1044.
131)Bevacizumab-containing chemotherapy for non-small cell lung cancer patients: a population-based observational study by the Ibaraki thoracic integrative (POSITIVE) research group.
Nakamura H, Satoh H, Kaburagi T, Nishimura Y, Shinohara Y, Inagaki M, Endo T, Saito T, Hayashihara K, Hizawa N, Kurishima K, Nawa T, Kagohashi K, Kishi K, Ishikawa H, Ichimura H, Hashimoto T, Sato Y, Sakai M, Kamiyama K, Matsumura T, Unoura K, Furukawa K.
Med Oncol. 2012 Dec;29(5):3202-6.
132)Obstructive jaundice as recurrence of lung adenocarcinoma.
Nakazawa K, Tamura T, Sato S, Kagohashi K, Kurishima K, Satoh H.
J Gastrointest Cancer. 2013 Jun;44(2):248-9.
133)Gemcitabine-induced pulmonary toxicity in a patient with pancreatic cancer.
Hiraya D, Kagohashi K, Sakamoto N, Kondo T, Satoh H.
JOP. 2010 Mar 5;11(2):186-8.
134)Bronchial asthma in the very elderly.
Kagohashi K, Satoh H, Sekizawa K.
Chest. 2002 Oct;122(4):1501.
135)Peritoneal relapse from lung adenocarcinoma after a response to EGFR-TKI.
Satoh H, Kagohashi K, Kurishima K.
Tuberk Toraks. 2013;61(4):346-7.
136)Successfully treated eosinophilic pneumonia in an octogenarian.
Kurishima K, Kagohashi K, Ohara G, Tamura T, Kawaguchi M, Satoh H.
Tuberk Toraks. 2012;60(1):98-9.
137)Pseudotumor by lateral process of the vertebra.
Tamura T, Ohara G, Kagohashi K, Satoh H.
Tuberk Toraks. 2015 Sep;63(3):210-1.
138)Docetaxel vs. vinorelbine in elderly patients with advanced non-small-cell lung cancer.
Kurishima K, Kagohashi K, Ishikawa H, Satoh H.
Clin Lung Cancer. 2012 Sep;13(5):396; author reply 397.
139)Incidentally detected lung cancer.
Kurishima K, Kagohashi K, Nakayama H, Satoh H.
South Med J. 2009 Sep;102(9):986.
140)Diagnostic procedures for small pulmonary nodules detected by mass-screening.
Kanemoto K, Satoh H, Ishikawa H, Kagohashi K, Kurishima K, Sekizawa K.
Anticancer Res. 2008 Sep-Oct;28(5B):3153-5.
141)An unusual cause of chest pain.
Hosoi T, Kagohashi K, Satoh H.
South Med J. 2011 Feb;104(2):155.
142)Long-term survivors after chemotherapy in advanced non-small cell lung cancer.
Satoh H, Ishikawa H, Ohara G, Kagohashi K, Kurishima K, Ohtsuka M, Hizawa N.
Anticancer Res. 2007 Nov-Dec;27(6C):4457-60.
143)Gefitinib is an additional prognostic factor in metastatic lung adenocarcinoma.
Kagohashi K, Satoh H, Ohtsuka M.
Respirology. 2006 Nov;11(6):835; author reply 836.
144)Thoracic radiotherapy for mediastinal nodal recurrence.
Kagohashi K, Nakayama H, Kagei K, Kurishima K, Ishikawa H, Satoh H.
Acta Medica (Hradec Kralove). 2009;52(1):23-5.
145) [A case of thymoma and Mycobacterium intracellulare infection].
Satoh H, Kagohashi K, Ohara G, Miyazaki Z, Kawaguchi M, Kurishima K, Ishikawa H.
Kekkaku. 2012 Nov;87(11):701-5.
146) Bone metastasis as the first manifestation of lung cancer.
Kagohashi K, Satoh H, Ishikawa H, Ohtsuka M, Sekizawa K.
Int J Clin Pract. 2003 Apr;57(3):184-6.
147)[Hemoptysis in a patient with old pulmonary tuberculosis showing atypical findings in chest computed tomography].
Satoh H, Kagohashi K, Ohara G, Miyazaki K, Kawaguchi M, Kurishima K, Ishikawa H.
Kekkaku. 2012 Oct;87(10):655-8.
148)Small large-cell neuroendocrine carcinoma in a patient with pulmonary emphysema.
Kagohashi K, Satoh H, Kurishima K, Kikuchi N, Ishikawa H, Sekizawa K.
Tuberk Toraks. 2009;57(1):77-80.
149)Intussusception due to intestinal metastasis from lung cancer.
Kagohashi K, Kadono K, Satoh H, Ohtsuka M.
Lung Cancer. 2007 Aug;57(2):247-8.
150) Incidentally detected colon cancer during the staging workup for lung cancer.
Lin SY, Kagohashi K, Satoh H.
Clin Lung Cancer. 2009 Mar;10(2):135; author reply 136.
